Drugs / Vaccine Poliomyelitis Inactivated
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06577298 Comparator | Dec 2024 → Oct 2026 expected | poliomyelitis | CanSino Biologics Inc. | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaccine Poliomyelitis Inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06577298 ↗ |
| Known as | IPV | “Vaccine Poliomyelitis Inactivated (IPV)” NCT06577298 ↗ |
| Modality | Vaccine | “IPV vaccine” NCT06577298 ↗ |
| Route | Intramuscular | “Phase I, Infant Group B, Control vaccine, IM” NCT06577298 ↗ |